We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.09B
AUM Growth
-$162M
Cap. Flow
-$297M
Cap. Flow %
-7.27%
Top 10 Hldgs %
11.04%
Holding
272
New
28
Increased
25
Reduced
198
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 25.53%
2 Healthcare 16.41%
3 Industrials 15.63%
4 Financials 14.82%
5 Consumer Discretionary 11.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JELD icon
126
JELD-WEN Holding
JELD
$162M
$13.2M 0.32%
429,451
-20,353
-5% -$738K
ESPR
127
DELISTED
Esperion Therapeutics
ESPR
$13M 0.32%
179,463
-76,629
-30% -$5.63M
VRTX icon
128
Vertex Pharmaceuticals
VRTX
$133B
$12.5M 0.3%
+76,447
New +$12.5M
TYL icon
129
Tyler Technologies
TYL
$13B
$12.5M 0.3%
59,037
-223
-0.4% -$44.6K
SBUX icon
130
Starbucks
SBUX
$119B
$12.4M 0.3%
214,779
-809
-0.4% -$46.8K
ILMN icon
131
Illumina
ILMN
$29B
$12.1M 0.3%
+52,557
New +$12M
VRSK icon
132
Verisk Analytics
VRSK
$23.6B
$12.1M 0.3%
116,139
-446
-0.4% -$44.5K
TRHC
133
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$12M 0.29%
309,613
-15,578
-5% -$546K
CERS icon
134
Cerus
CERS
$508M
$11.7M 0.28%
2,126,153
-714,351
-25% -$3.25M
DK icon
135
Delek US
DK
$3.72B
$11.6M 0.28%
284,807
-64,440
-18% -$2.32M
ZOES
136
DELISTED
Zoe's Kitchen, Inc.
ZOES
$11.4M 0.28%
789,064
-44,261
-5% -$665K
KTWO
137
DELISTED
K2M Group Holdings, Inc
KTWO
$11.3M 0.28%
596,598
-292,159
-33% -$5.79M
MMSI icon
138
Merit Medical Systems
MMSI
$5.36B
$11M 0.27%
242,983
-55,300
-19% -$2.5M
CCS icon
139
Century Communities
CCS
$1.96B
$11M 0.27%
367,063
-82,839
-18% -$2.63M
SBNY
140
DELISTED
Signature Bank
SBNY
$10.7M 0.26%
75,519
-3,536
-4% -$533K
VCRA
141
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$10.7M 0.26%
456,139
-22,389
-5% -$599K
TILE icon
142
Interface
TILE
$2.18B
$10.7M 0.26%
422,655
-95,686
-18% -$2.37M
GDEN
143
DELISTED
Golden Entertainment
GDEN
$10.4M 0.26%
+449,140
New +$13M
CELG
144
DELISTED
Celgene Corp
CELG
$10.3M 0.25%
115,334
-51,597
-31% -$4.95M
LKFT
145
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$10.2M 0.25%
102,136
-15,075
-13% -$1.62M
PCRX icon
146
Pacira BioSciences
PCRX
$974M
$10.2M 0.25%
326,056
-40,547
-11% -$1.44M
KMPR icon
147
Kemper
KMPR
$1.55B
$10M 0.24%
175,639
-39,627
-18% -$2.43M
NTUS
148
DELISTED
Natus Medical Inc
NTUS
$9.91M 0.24%
+294,560
New +$9.32M
VC icon
149
Visteon
VC
$2.8B
$9.91M 0.24%
89,860
-20,261
-18% -$2.53M
LNTH icon
150
Lantheus
LNTH
$6.59B
$9.9M 0.24%
622,684
+202,312
+48% +$3.94M

Similar funds

Peregrine Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Peregrine Capital Management held 272 positions worth $4.09B, down 3.8% from $4.25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Peregrine Capital Management withdrew a net $297M in Q1 2018, closing 21 positions and reducing 198 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $18.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Peregrine Capital Management opened a new position in Lumentum worth $38.7M.

  • Peregrine Capital Management's largest Q1 2018 buy was Lumentum: 605,857 shares worth $38.7M.
  • Peregrine Capital Management added most to Fox Factory Holding Corp in Q1 2018, an estimated $6.71M increase.
  • Peregrine Capital Management's biggest Q1 2018 reduction was Virtu Financial, cutting an estimated $17.7M.
  • Peregrine Capital Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $18.4M.
  • Peregrine Capital Management's ten largest holdings make up 11% of its $4.09B portfolio in Q1 2018.
  • Peregrine Capital Management opened 28 new positions and closed 21 in Q1 2018.
  • Peregrine Capital Management's portfolio value fell 3.8% quarter-over-quarter to $4.09B.

Based on Peregrine Capital Management's 13F filing for Q1 2018, filed 16 Apr 2018.